Brunswick Corporation (BC) capitalization

Current snapshot

Market Cap
$4.76B
65.0M shares × $73.30 · as of last filing 2026-04-04
Net Worth
$1.60B
Stockholders' equity · 2026-04-04
Enterprise Value
$6.93B
Market cap + debt − cash
Net Debt
$2.16B
Debt $2.44B − Cash $277.8M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $4.89B
FY'24 2024-12-31 $4.36B
FY'23 2023-12-31 $6.82B
FY'22 2022-12-31 $5.42B
FY'20 2021-12-31 $7.90B
FY'20 2020-12-31 $6.08B
FY'19 2019-12-31 $5.13B
FY'18 2018-12-31 $4.10B
FY'17 2017-12-31 $4.98B
FY'16 2016-12-31 $5.02B
FY'15 2015-12-31 $4.76B
FY'14 2014-12-31 $4.87B
FY'13 2013-12-31 $4.32B
FY'12 2012-12-31 $2.69B
FY'11 2011-12-31 $1.67B
FY'11 2010-12-31 $1.66B
FY'11 2009-12-31 $1.12B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-04-04 $4.82B
Q4'25 2025-12-31 $4.82B
Q3'25 2025-09-27 $4.18B
Q2'25 2025-06-28 $3.67B
Q1'25 2025-03-29 $3.55B
Q4'24 2024-12-31 $4.27B
Q3'24 2024-09-28 $5.63B
Q2'24 2024-06-29 $4.92B
Q1'24 2024-03-30 $6.61B
Q4'23 2023-12-31 $6.60B
Q3'23 2023-09-30 $5.53B
Q2'23 2023-07-01 $6.14B
Q1'23 2023-04-01 $5.89B
Q4'22 2022-12-31 $5.14B
Q3'22 2022-10-01 $4.88B
Q1'22 2022-07-02 $5.06B
Q1'22 2022-04-02 $6.21B
Q4'20 2021-12-31 $7.75B
Q3'21 2021-10-02 $7.62B
Q2'21 2021-07-03 $7.74B
Q1'21 2021-04-03 $7.64B
Q4'20 2020-12-31 $5.94B
Q3'20 2020-09-26 $4.69B
Q2'20 2020-06-27 $4.98B
Q1'20 2020-03-28 $2.86B
Q4'19 2019-12-31 $4.77B
Q3'19 2019-09-28 $4.40B
Q2'19 2019-06-29 $4.01B
Q1'19 2019-03-30 $4.43B
Q4'18 2018-12-31 $3.70B
Q3'18 2018-09-29 $5.89B
Q2'18 2018-06-30 $5.69B
Q1'18 2018-03-31 $5.27B
Q4'17 2017-12-31 $4.83B
Q3'17 2017-09-30 $5.03B
Q2'17 2017-07-01 $5.68B
Q1'17 2017-04-01 $5.58B
Q4'16 2016-12-31 $4.87B
Q3'16 2016-10-01 $4.48B
Q2'16 2016-07-02 $4.30B
Q1'16 2016-04-02 $4.48B
Q4'15 2015-12-31 $4.59B
Q3'15 2015-10-03 $4.50B
Q2'15 2015-07-04 $4.80B
Q1'15 2015-04-04 $4.89B
Q4'14 2014-12-31 $4.75B
Q3'14 2014-09-27 $4.11B
Q2'14 2014-06-28 $4.01B
Q1'14 2014-03-29 $4.24B
Q4'13 2013-12-31 $4.26B
Q3'13 2013-09-28 $3.75B
Q2'13 2013-06-29 $2.99B
Q1'13 2013-03-30 $3.20B
Q4'12 2012-12-31 $2.62B
Q3'12 2012-09-29 $2.09B
Q2'12 2012-06-30 $2.05B
Q1'12 2012-03-31 $2.38B
Q4'11 2011-12-31 $1.61B
Q3'11 2011-10-01 $1.29B
Q2'11 2011-07-02 $1.98B
Q1'11 2011-04-02 $2.37B
Q4'11 2010-12-31 $1.66B
Q3'11 2010-10-02 $1.36B
Q2'11 2010-07-03 $1.14B
Q1'11 2010-04-03 $1.39B
Q4'11 2009-12-31 $1.12B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (BC CIK 0000014930), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NYT

THE NEW YORK TIMES COMPANY

WY

WEYERHAEUSER COMPANY

ESPR

Esperion Therapeutics, Inc.